Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. R-cizolirtine
2. Cizolirtine, (+)-
3. (r)-(+)-cizolirtine
4. (r)-cizolirtine
5. Wl3jtg8v2h
6. 148981-62-8
7. Unii-wl3jtg8v2h
8. Cizolirtine, (r)-
9. Chembl92357
10. Schembl2776433
11. Q27292702
| Molecular Weight | 259.35 g/mol |
|---|---|
| Molecular Formula | C15H21N3O |
| XLogP3 | 1.7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 6 |
| Exact Mass | 259.168462302 g/mol |
| Monoisotopic Mass | 259.168462302 g/mol |
| Topological Polar Surface Area | 30.3 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 254 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Cizolirtine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cizolirtine, including repackagers and relabelers. The FDA regulates Cizolirtine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cizolirtine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cizolirtine supplier is an individual or a company that provides Cizolirtine active pharmaceutical ingredient (API) or Cizolirtine finished formulations upon request. The Cizolirtine suppliers may include Cizolirtine API manufacturers, exporters, distributors and traders.
click here to find a list of Cizolirtine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cizolirtine DMF (Drug Master File) is a document detailing the whole manufacturing process of Cizolirtine active pharmaceutical ingredient (API) in detail. Different forms of Cizolirtine DMFs exist exist since differing nations have different regulations, such as Cizolirtine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cizolirtine DMF submitted to regulatory agencies in the US is known as a USDMF. Cizolirtine USDMF includes data on Cizolirtine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cizolirtine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cizolirtine suppliers with USDMF on PharmaCompass.
Cizolirtine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cizolirtine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cizolirtine GMP manufacturer or Cizolirtine GMP API supplier for your needs.
A Cizolirtine CoA (Certificate of Analysis) is a formal document that attests to Cizolirtine's compliance with Cizolirtine specifications and serves as a tool for batch-level quality control.
Cizolirtine CoA mostly includes findings from lab analyses of a specific batch. For each Cizolirtine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cizolirtine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cizolirtine EP), Cizolirtine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cizolirtine USP).
LOOKING FOR A SUPPLIER?
